Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
"The Road Less Traveled: Leveraging an Unconventional Career Path"
Summary
In this episode, Tom Caravela is joined by Marc Bernarducci to explore the evolving role of Medical Science Liaisons. Marc shares insights from his educational journey and transition into the industry, highlighting the significance of networking and tenacity. He emphasizes patience and coachability during job searches and new roles, and discusses the complexities of the MSL position, including learning from mistakes. The conversation shifts to adapting to digital platforms and preparing for the post-COVID landscape, stressing the importance of adaptability. Marc concludes with valuable advice for aspiring MSLs, followed by closing remarks and holiday wishes.
Marc Bernarducci, Sr Medical Science Liaison shares ideas on leveraging an unconventional career path to find success.
In this episode we discuss:
- Marc’s education and where his career began
- What made him want to transition to industry and how did he go about it
- How he landed in medical affairs and why he wanted to be an MSL
- His perspective on “unconventional” career path
- His advice for others who are looking to break into their first MSL role
- His other advice to those that are looking to build a career in Medical Affairs
Medical Science Liaison, Marc Bernarducci, MSL career advice, unconventional career path, transitioning to industry
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO